Kenneth A. Bauer, MD

Professor of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

How would you manage VTE risk in a transgender patient who needs hormone replacement therapy? Friday, February 2nd, 2018
This month, Kenneth A. Bauer, MD, discusses venous thromboembolism (VTE) risk in a transgender patient who needs hormone replacement therapy. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!

Is it reasonable to use rivaroxaban as an antithrombotic drug in obese patients? Thursday, January 1st, 2015
This month, Kenneth A. Bauer, MD, advises on the use of target-specific oral anticoagulants in obese patients.